Notice NOT-MD-23-014 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-312 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-311 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-310 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-119 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-23-025 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-22-028 to comply with DMSP - No new dates are being added. Reissue of:RFA-NS-18-029 and RFA-NS-20-029. This funding opportunity announcement (FOA) is designed to support teams of investigators that seek to cross boundaries of interdisciplinary collaboration to elucidate the contributions of dynamic circuit activity to a specific behavioral or neural system. Applications are encouraged to propose adventurous and challenging goals that can only be tackled by a synergistic team-based approach and have the potential to be transformative and/or to enable significant advances. These studies at the exploratory stage are intended for the development of experimental capabilities and/or theoretical frameworks in preparation for a future competition for larger-scale or extended efforts, including the BRAIN TargetedBCP R01 or the multi-component, Team-Research BRAIN Circuit Programs (U19). The overall goal of this FOA is to enable a large-scale analysis of neural systems and circuits within the context and during the simultaneous measurement of an ethologically relevant behavior. Toward this end, teams are expected to assemble and leverage multi-disciplinary expertise, and to integrate experimental with computational and theoretical approaches. Teams are expected to bridge fields by incorporating rich information on cell-types, on circuit functionality and connectivity, in conjunction with sophisticated analyses of an ethologically relevant behavior of an organism or a well-defined neural system. Teams are also expected to aim for a mechanistic understanding of the circuits of the central nervous system (CNS) by applying cutting-edge methods such as those for large-scale recording, manipulation, and analysis of neural circuits across multiple regions of the CNS.

Notice NOT-AT-24-004 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-120 from the NIH Guide for Grants and Contracts

Notice NOT-ES-23-011 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-006 from the NIH Guide for Grants and Contracts

Notice NOT-HG-23-040 from the NIH Guide for Grants and Contracts

Notice NOT-HG-23-039 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-062 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-063 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-24-039 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the development of innovative tools and/or technologies to monitor or manipulate biomolecular condensates (BMCs) in vivo and enable investigators to adopt these tools to answer outstanding questions in basic neuroscience. This research will transform our understanding of the mechanistic role of BMCs in human nervous system health and disease and may serve as the foundation for the development of novel BMC-based therapeutics.

Funding Opportunity PAR-23-145 from the NIH Guide for Grants and Contracts. The Maximizing Investigators' Research Award (MIRA) under this Notice of Funding Opportunity (NOFO) provides support for a program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. For the purpose of this NOFO, a program of research is a collection of projects in the investigator's lab that are relevant to the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding.

Notice NOT-OD-23-110 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-179 from the NIH Guide for Grants and Contracts. This Small Research Grant (R03) will support meritorious projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Specifically, this NOFO will support projects covering a wide range of topics related to AD/ADRD. The overall goal of this NOFO is (i) to encourage the next generation of researchers to pursue research and academic careers in AD/ADRD research; and (ii) to stimulate established researchers who have not had a major award in AD/ADRD research to perform pilot studies to develop new, innovative AD/ADRD research programs that leverage and build upon their existing expertise.

Notice NOT-HG-23-036 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-23-035 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This FOA seeks to address both challenges simultaneously by having two equally important goals: entrepreneurial mentoring support, and product development support.